⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 20, 2024Canadian Health PolicyOpen Access

Benefit of expedited regulatory approval for oncology drugs eliminated by slow reimbursement reviews and price negotiations

Nigel S. B. Rawson David J. Stewart

View Full Paper

Ask AI

Bookmark

Share

Abstract

Benefit of expedited regulatory approval for oncology drugs eliminated by slow reimbursement reviews and price negotiations Nigel S B Rawson and David J Stewart ABSTRACT Summary: In an examination of 92 oncology drugs that received regulatory approval

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rawson et al. (2024) studied this question.

synapsesocial.com/papers/68e5bb1eb6db643587552c96 https://doi.org/10.54194/kjry1417

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mapping benefits, risks, and challenges of expedited drug approval programsHuman Clinical Trial · 2026
2Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysisSystematic Review · 2026 · 1 citations
3Is Canada Moving towards a More Agile Regulatory Approval and a Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?2024 · 7 citations
4Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval2024 · 129 citations
5Is Canada Moving towards a More Agile Regulatory Approval and Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?2024 · 7 citations

Expedited pathway portfolios, trial complexity, and FDA approval timelines in oncology and neurology: A comparative analysis2026
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study2024
A Cross-National Review of Novel Oncology Approvals in the United States and China (2020–2025)2026
Exploring the Ethics of Paediatric Surgical Prioritization in Canada: A Survey of Existing Institutional GuidanceCanadian Health Policy · 2024
A Growing Problem: Is Canada’s Healthcare System Keeping Up with Newcomers?Canadian Health Policy · 2024

More from Canadian Health Policy